Android Apple

4D Molecular Therapeutics, Inc. (FDMT) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$5.81

south_east -$0.07 (-1.19%)
Day's range
$5.7
Day's range
$5.89

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
09/19/2024 BMO Capital Kostas Biliouris $40.00 $13.28   201.2%
09/19/2024 Loop Capital Markets Geulah Livshits $39.00 $13.31   192.99%
09/19/2024 H.C. Wainwright Matthew Caufield $36.00 $13.31   170.44%
04/15/2024 RBC Capital Lisa Walter $40.00 $26.35   51.8%
04/14/2024 Barclays Gena Wang $45.00 $26.35   70.78%
04/01/2024 Jefferies Nalin Tejavibulya $58.00 $31.86   82.05%
03/28/2024 BMO Capital Kostas Biliouris $63.00 $31.59   99.43%
02/06/2024 BMO Capital Kostas Biliouris $70.00 $30.71   127.98%
07/05/2023 Chardan Capital Geulah Livshits $30.00 $18.43   62.78%
No analyst forecast available for this stock.

4D Molecular Therapeutics, Inc. FAQ's

What analysts cover 4D Molecular Therapeutics, Inc.?

4D Molecular Therapeutics, Inc. has been rated by research analysts at BMO Capital, Loop Capital Markets, H.C. Wainwright, RBC Capital, Barclays, Jefferies in the past 90 days.

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.